Siti Pradyta Phiskanugrah
Unknown Affiliation

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

The Eye as a Window to Neuroinflammation in Psychiatric Disorders?: A Meta-Analysis of Retinal Structural and Vascular Biomarkers Ramzi Amin; Siti Pradyta Phiskanugrah
Scientia Psychiatrica Vol. 6 No. 4 (2025): Scientia Psychiatrica
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/scipsy.v6i2.186

Abstract

Introduction: Psychiatric disorders like schizophrenia, bipolar disorder (BD), and major depressive disorder (MDD) represent major global health challenges with complex pathophysiology, potentially involving neuroinflammation. The retina, an extension of the central nervous system (CNS), offers an accessible site for investigating structural and vascular changes that may parallel CNS processes. Optical Coherence Tomography (OCT) and OCT Angiography (OCT-A) allow non-invasive, high-resolution assessment of retinal neural and vascular layers. This study aimed to meta-analyze current evidence on retinal structural and vascular alterations in major psychiatric disorders and explore these findings within the conceptual framework of shared neuroinflammatory pathways. Methods: A systematic literature search was conducted in PubMed, Scopus, and Web of Science databases for studies published between January 1st, 2013, and December 31st, 2024. We included case-control studies comparing OCT and/or OCT-A parameters (Retinal Nerve Fiber Layer [RNFL] thickness, Ganglion Cell-Inner Plexiform Layer [GCL-IPL] thickness, Macular Thickness [MT], Superficial Capillary Plexus Vessel Density [SCP-VD], Deep Capillary Plexus Vessel Density [DCP-VD], and Foveal Avascular Zone [FAZ] area) between patients with diagnosed schizophrenia, BD, or MDD and healthy controls (HC). Data were pooled using a random-effects model, calculating Standardized Mean Differences (SMD) with 95% confidence intervals (CI). Heterogeneity was assessed using I² statistics. The risk of bias was evaluated using the Newcastle-Ottawa Scale (NOS). Results: Seven studies met the inclusion criteria, encompassing a total of 485 patients (180 Schizophrenia, 155 BD, 150 MDD) and 515 healthy controls. Patients with psychiatric disorders exhibited significantly thinner global RNFL (SMD = -0.68; 95% CI [-0.95, -0.41]; p < 0.00001; I²=75%), GCL-IPL (SMD = -0.75; 95% CI [-1.08, -0.42]; p < 0.0001; I²=80%), and reduced macular SCP-VD (SMD = -0.55; 95% CI [-0.88, -0.22]; p = 0.001; I²=72%) compared to HC. DCP-VD also showed a trend towards reduction (SMD = -0.40; 95% CI [-0.85, 0.05]; p = 0.08; I²=79%). No significant difference was found in central macular thickness (SMD = -0.15; 95% CI [-0.45, 0.15]; p = 0.33; I²=60%) or FAZ area (SMD = 0.20; 95% CI [-0.10, 0.50]; p = 0.19; I²=55%). High heterogeneity was observed across most analyses. Study quality varied, with NOS scores ranging from 6 to 8. Conclusion: This meta-analysis confirms consistent findings of inner retinal neural thinning and microvascular density reduction in individuals with major psychiatric disorders. These alterations, detectable non-invasively via OCT/OCT-A, align with the hypothesis of shared pathophysiological mechanisms, potentially involving neuroinflammation and microvascular compromise, affecting both the brain and the retina. While providing indirect support, these findings underscore the retina's potential as a valuable site for biomarker research in psychiatry.
Small-Gauge (25/27G) versus 23-Gauge Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment Repair: A Meta-Analysis of Surgical Efficiency, Anatomical Success, and Postoperative Complications Ramzi Amin; Siti Pradyta Phiskanugrah
Sriwijaya Journal of Surgery Vol. 7 No. 1 (2024): Sriwijaya Journal of Surgery
Publisher : Surgery Department, Faculty of Medicine Universitas Sriwijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/sjs.v7i1.121

Abstract

Introduction: Pars plana vitrectomy (PPV) is a cornerstone surgical treatment for rhegmatogenous retinal detachment (RRD). The evolution from traditional 20-gauge (G) systems to microincision vitrectomy surgery (MIVS) using 23G, 25G, and 27G instruments has aimed to reduce surgical trauma and improve postoperative recovery. However, the relative merits of smaller gauges (25/27G) compared to the widely adopted 23G system, specifically for RRD repair, remain debated, particularly regarding surgical efficiency, anatomical outcomes, and complication profiles. This meta-analysis aimed to synthesize available evidence comparing 25/27G MIVS with 23G MIVS for primary RRD repair. Methods: A systematic literature search was conducted across PubMed, Embase, Scopus, and the Cochrane Library for comparative studies published between January 1st, 2013, and December 31st, 2023. Studies comparing 25G or 27G PPV against 23G PPV for primary RRD repair and reporting on surgical time, primary anatomical success (PAS), final anatomical success (FAS), or relevant postoperative complications were included. Data were extracted independently by two reviewers. A random-effects model was used for meta-analysis to calculate pooled Odds Ratios (OR) for dichotomous outcomes and Mean Differences (MD) for continuous outcomes, with 95% confidence intervals (CIs). Heterogeneity was assessed using the I² statistic. Results: Six comparative studies involving a total of 1050 eyes (520 eyes in the 25/27G group, 530 eyes in the 23G group) met the inclusion criteria. Meta-analysis indicated no statistically significant difference in surgical time between the small-gauge (25/27G) and 23G groups (MD: 2.15 minutes, 95% CI: -1.80 to 6.10, P=0.28; I²=65%). Primary anatomical success rates were comparable between groups (OR: 0.92, 95% CI: 0.65 to 1.30, P=0.63; I²=15%). Analysis of postoperative complications revealed a trend towards higher rates of early transient hypotony in the 25/27G group, although not statistically significant in the pooled analysis (OR: 1.85, 95% CI: 0.90 to 3.80, P=0.09; I²=30%). Rates of endophthalmitis, choroidal detachment, significant PVR development, and cataract progression appeared similar, though data were limited for some outcomes. Conclusion: Small-gauge (25/27G) PPV demonstrated comparable surgical efficiency (time), primary anatomical success, and final anatomical success to 23G PPV for the repair of primary RRD. While a potential trend towards increased early postoperative hypotony exists with smaller gauges, overall complication rates, including PVR and endophthalmitis, were not significantly different. The choice of gauge size for RRD repair may depend on surgeon preference, specific case characteristics, and available instrumentation, as current evidence suggests broadly similar core outcomes. Further large-scale RCTs with standardized protocols and long-term follow-up are warranted.
Comparative Efficacy and Safety of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration: A Meta-Analysis Ramzi Amin; Siti Pradyta Phiskanugrah
Open Access Indonesian Journal of Medical Reviews Vol. 5 No. 1 (2025): Open Access Indonesian Journal of Medical Reviews
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/oaijmr.v5i1.723

Abstract

Neovascular age-related macular degeneration (nAMD) is a leading cause of vision loss in the elderly. This meta-analysis aims to compare the efficacy and safety of various anti-VEGF agents, including ranibizumab, bevacizumab, aflibercept, and brolucizumab, in the treatment of nAMD. A comprehensive understanding of the comparative effectiveness of these agents is crucial for informing clinical decision-making and optimizing treatment strategies. A meta-analysis was conducted using electronic databases, including PubMed, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL), to identify relevant randomized controlled trials (RCTs) published between 2013 and 2024. The search strategy involved a combination of Medical Subject Headings (MeSH) terms and keywords. Two independent reviewers extracted data from the included studies using a standardized form. The extracted data included study characteristics, patient demographics, treatment details, visual acuity outcomes, and safety profiles. Seven RCTs were included in the meta-analysis. The analysis revealed that all anti-VEGF agents resulted in significant improvements in visual acuity compared to control. Notably, aflibercept and brolucizumab demonstrated greater improvements in visual acuity at 12 months compared to ranibizumab and bevacizumab. The incidence of ocular adverse events, including endophthalmitis, intraocular inflammation, and retinal detachment, was similar across the anti-VEGF agents. All anti-VEGF agents are effective in improving visual acuity in nAMD. Aflibercept and brolucizumab may offer superior visual acuity outcomes compared to ranibizumab and bevacizumab. The safety profiles of these agents are generally comparable, although brolucizumab may be associated with a slightly higher risk of intraocular inflammation.